Multiple Sclerosis Trial, Recruiting NCT07451600 Sponsor: Ankara Etlik City Hospital Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07451600
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 60 years old
  • People who have been diagnosed with multiple sclerosis for more than six months
  • People whose muscle stiffness falls within a moderate range, measured as a score of 1 to 3 on a standard stiffness scale called the Modified Ashworth Scale (MAS) (confirm with trial site)
  • People whose level of disability, measured by a standard MS scoring tool called the EDSS, falls between 0 and 6.5 (confirm with trial site)
  • People who are willing to take part in the study voluntarily

Who may not be able to join:

  • People who are in poor general health, such as those with heart failure or serious lung conditions
  • People who have open wounds or skin lesions in the area being treated
  • People who have metal implants anywhere in their body
  • People who are pregnant
  • People who currently have a severe infection
  • People who have been diagnosed with cancer
  • People who have a bleeding disorder
  • People who use a pacemaker
  • People who have a heart rhythm disorder
  • People who have a neurological condition other than multiple sclerosis
  • People who have a history of epilepsy
  • People who have a history of alcohol use
  • People whose medication has changed within the last 6 months
  • People who do not wish to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Özgür Zeliha Karaahmet, professor, Ankara Etlik City Hospital

Phone: +90 0312 797 00 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara Etlik City Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 October 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Modified Ashworth Scale; Penn Spasm Frequency Scale; Modified Tardieu Scale; BERG Balance Scale; Goal Attainment Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov